Randomized Controlled Trial of Stress Management Training in HIV (SWISSIT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00436085 |
Recruitment Status
:
Completed
First Posted
: February 16, 2007
Last Update Posted
: February 16, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Behavioral: Cognitive behavioral stress management training | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Controlled Trial of Stress Management Training in Individuals With HIV Infection |
Study Start Date : | December 2003 |
Study Completion Date : | December 2005 |

- CD4 cell count
- HIV viral load
- Depression and Anxiety
- QUality of life

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults between 18 and 65 years of age
- Sufficient German-speaking abilities to participate in group therapy
- cARTwithin the previous three months,
- CD4 lymphocyte count above 100 cells/mL
Exclusion Criteria:
- Active opportunistic infection at baseline
- Formal psychotherapy within the previous three months
- Intravenous drug users
- Diagnosable current major psychiatric disorder (bipolar affective disorder, psychotic disorders, major depression with melancholia) and diagnosis of antisocial and borderline personality disorders at baseline

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00436085
Switzerland | |
University Hospital Zurich | |
Zuerich, Switzerland, 8006 |
Principal Investigator: | Jens Gaab, PhD | Clinical Psychology and PSychotherapy, Institute of Psychology, University of Zürich | |
Principal Investigator: | Rainer Weber, MD | University Hospital, Zürich | |
Principal Investigator: | Ulrike Ehlert, PhD | Clinical Psychology and Psychotherapy, Institute of Psychology, University of Zurich |
ClinicalTrials.gov Identifier: | NCT00436085 History of Changes |
Other Study ID Numbers: |
3346C0-100907 |
First Posted: | February 16, 2007 Key Record Dates |
Last Update Posted: | February 16, 2007 |
Last Verified: | February 2007 |
Additional relevant MeSH terms:
Infection HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |